Nilutamide
目录号: A21165
Androgen receptor antagonist
Nilutamide(Nilandron)是一种非甾体抗雄激素药物,用于治疗转移性前列腺癌。
Androgen receptor antagonist
Discription | Nilutamide (Nilandron) is a non-steroidal anti-androgen drug proposed in the treatment of metastatic prostatic carcinoma. |
---|
目录号 | A21165 |
---|---|
分子式 | C12H10F3N3O4 |
分子量 | 317.22 |
CAS号 | 63612-50-0 |
SMILES | O=C1N(C2=CC=C([N+]([O-])=O)C(C(F)(F)F)=C2)C(C(C)(C)N1)=O |
其他名称 | Nilandron; RU 23908, RU23908, RU-23908 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 54 mg/mL (170.23 mM) | |
Water | Insoluble | ||
Ethanol | 54 mg/mL | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 31.52 mL | 157.62 mL | 315.24 mL |
0.5 mM | 6.3 mL | 31.52 mL | 63.05 mL |
1 mM | 3.15 mL | 15.76 mL | 31.52 mL |
5 mM | 0.63 mL | 3.15 mL | 6.3 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2